Pear Therapeutics, a pioneer in digital therapeutics, has recently been navigating troubled waters. This article explores the recent...

Araris Biotech AG, a frontrunner in the development of proprietary antibody-drug conjugate (ADC)-linker technology, has recently secured...

Global life sciences investor, Novo Holdings, has made a strategic investment in Alentis Therapeutics, a clinical-stage biotechnology...

Alentis Therapeutics, a biotech powerhouse known for its innovative drug research, has recently raised a whopping $105 million. This...

TORL BioTherapeutics, an emerging biopharmaceutical company, has recently made waves in the biotech industry. By successfully closing a...

Gilde Healthcare, a prominent healthcare investor, has recently announced a significant monetary commitment of €600 million towards their...

Vaxcyte, Inc. (NASDAQ: PCVX), a pioneering company specializing in the development of high-quality vaccines, recently concluded a...

AB Science, a renowned pharmaceutical company, recently marked a pivotal milestone by successfully raising €15 million via private...

Baudax Bio, Inc, a renowned pharmaceutical company with a focus on hospital-oriented products, recently triumphed in the financial market...